Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Nasopharyngeal Carcinoma 4Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Uterine Cervical Neoplasms 2Nasopharyngeal Neoplasms 2Esophageal Neoplasms 2Stomach Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Nasopharyngeal Diseases 1Colorectal Neoplasms 1Carcinoma 1

Interventions

Cisplatin 53Paclitaxel 27Carboplatin 22Brachytherapy 18Radiotherapy 17human papillomavirus vaccine, L1 type 16, 18 12Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12Gemcitabine 12Topotecan 8Vaccines, Synthetic 7Platinum 7Papillomavirus Vaccines 7Radiation 6Bevacizumab 61,2-diaminocyclohexaneplatinum II citrate 6Neoadjuvant Therapy 5Chemotherapy, Adjuvant 5pembrolizumab 4Vinorelbine 4Radiotherapy, Intensity-Modulated 4Pemetrexed 4Drug Therapy 4Taxes 3Surgical Procedures, Operative 3Ondansetron 3Irinotecan 3Dexamethasone 3Chemoradiotherapy 3tisotumab vedotin 2specific substance maruyama 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Uterine Cervical Neoplasms × nimotuzumab × Clear all
NCT06333821 2024-03-27

A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
460 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03413579 2021-08-25

CIMAHOPE

El Kendi Pharmaceuticals Manufacturing Company

Phase 3 Completed
37 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡